Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CardioCell in No-option Critical Limb Ischemia
NCT03423732Phase 3Unknown
- Sponsor
- Krakowski Szpital Specjalistyczny im. Jana Pawła II
- Start
- Apr 2018
- Primary completion
- May 2021
- Countries
- 1
01
Overview
A Phase 3 trial of ischemia-tolerant mesenchymal stem cells in critical limb ischemia (CLI), sponsored by Krakowski Szpital Specjalistyczny im. Jana Pawła II. Status: unknown.
02
Drugs
ischemia-tolerant mesenchymal stem cells
03
Conditions
critical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT03423732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03423732.